Trial Profile
Global phase I trial of biosimilar trastuzumab for Her2+ metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Aug 2013
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Biocon
- 13 Aug 2013 New trial record